153 related articles for article (PubMed ID: 7690053)
1. A new approach in the treatment of hypotension in human septic shock by NG-monomethyl-L-arginine, an inhibitor of the nitric oxide synthetase.
Schilling J; Cakmakci M; Bättig U; Geroulanos S
Intensive Care Med; 1993; 19(4):227-31. PubMed ID: 7690053
[TBL] [Abstract][Full Text] [Related]
2. Effects of a nitric oxide synthase inhibitor in humans with septic shock.
Petros A; Lamb G; Leone A; Moncada S; Bennett D; Vallance P
Cardiovasc Res; 1994 Jan; 28(1):34-9. PubMed ID: 7509259
[TBL] [Abstract][Full Text] [Related]
3. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock.
Petros A; Bennett D; Vallance P
Lancet; 1991 Dec 21-28; 338(8782-8783):1557-8. PubMed ID: 1720856
[TBL] [Abstract][Full Text] [Related]
4. Reversal of refractory hypotension in septic shock by inhibitor of nitric oxide synthase.
Lin PJ; Chang CH; Chang JP
Chest; 1994 Aug; 106(2):626-9. PubMed ID: 7539733
[TBL] [Abstract][Full Text] [Related]
5. Effects of nitric oxide synthase inhibition combined with nitric oxide inhalation in a porcine model of endotoxin shock.
Klemm P; Thiemermann C; Winklmaier G; Martorana PA; Henning R
Br J Pharmacol; 1995 Jan; 114(2):363-8. PubMed ID: 7533615
[TBL] [Abstract][Full Text] [Related]
6. Cyclic nucleotides and vasoactive intestinal peptide production in a rabbit model of Escherichia coli septicemia.
Broner CW; O'Dorisio MS; Rosenberg RB; O'Dorisio TM
Am J Med Sci; 1995 May; 309(5):267-77. PubMed ID: 7537447
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginine.
Kilbourn RG; Gross SS; Lodato RF; Adams J; Levi R; Miller LL; Lachman LB; Griffith OW
J Natl Cancer Inst; 1992 Jul; 84(13):1008-16. PubMed ID: 1376778
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial?
Nava E; Palmer RM; Moncada S
Lancet; 1991 Dec 21-28; 338(8782-8783):1555-7. PubMed ID: 1683974
[TBL] [Abstract][Full Text] [Related]
9. NG-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs.
Kilbourn RG; Cromeens DM; Chelly FD; Griffith OW
Crit Care Med; 1994 Nov; 22(11):1835-40. PubMed ID: 7956289
[TBL] [Abstract][Full Text] [Related]
10. Effects of endothelin-1 and inhibition of nitric oxide production with NG-monomethyl-L-arginine on arterial pressure and regional blood flow in anesthetized rats.
Takahashi H; Nakanishi T; Nishimura M; Tanaka H; Yoshimura M
J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S176-8. PubMed ID: 1282961
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of nitric oxide synthase in experimental gram-negative sepsis.
Evans T; Carpenter A; Silva A; Cohen J
J Infect Dis; 1994 Feb; 169(2):343-9. PubMed ID: 7508968
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans.
Stamler JS; Loh E; Roddy MA; Currie KE; Creager MA
Circulation; 1994 May; 89(5):2035-40. PubMed ID: 7514109
[TBL] [Abstract][Full Text] [Related]
13. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.
Rees DD; Palmer RM; Schulz R; Hodson HF; Moncada S
Br J Pharmacol; 1990 Nov; 101(3):746-52. PubMed ID: 1706208
[TBL] [Abstract][Full Text] [Related]
14. Use of nitric oxide synthase inhibitors as a novel treatment for septic shock.
Wolfe TA; Dasta JF
Ann Pharmacother; 1995 Jan; 29(1):36-46. PubMed ID: 7536056
[TBL] [Abstract][Full Text] [Related]
15. NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension.
Kilbourn RG; Fonseca GA; Griffith OW; Ewer M; Price K; Striegel A; Jones E; Logothetis CJ
Crit Care Med; 1995 Jun; 23(6):1018-24. PubMed ID: 7774211
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide-induced hypotension and vascular hyporeactivity in the rat: tissue analysis of nitric oxide synthase mRNA and protein expression in the presence and absence of dexamethasone, NG-monomethyl-L-arginine or indomethacin.
Hom GJ; Grant SK; Wolfe G; Bach TJ; MacIntyre DE; Hutchinson NI
J Pharmacol Exp Ther; 1995 Jan; 272(1):452-9. PubMed ID: 7529313
[TBL] [Abstract][Full Text] [Related]
18. Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock.
Robertson FM; Offner PJ; Ciceri DP; Becker WK; Pruitt BA
Arch Surg; 1994 Feb; 129(2):149-55; discussion 155-6. PubMed ID: 7508219
[TBL] [Abstract][Full Text] [Related]
19. Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study.
Avontuur JA; Tutein Nolthenius RP; van Bodegom JW; Bruining HA
Crit Care Med; 1998 Apr; 26(4):660-7. PubMed ID: 9559602
[TBL] [Abstract][Full Text] [Related]
20. Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis.
Kilbourn RG; Jubran A; Gross SS; Griffith OW; Levi R; Adams J; Lodato RF
Biochem Biophys Res Commun; 1990 Nov; 172(3):1132-8. PubMed ID: 2244897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
